Suppr超能文献

一种缺乏显著抗氧化特性的高选择性15-脂氧合酶抑制剂对兔饮食诱导动脉粥样硬化的抑制作用

Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties.

作者信息

Sendobry S M, Cornicelli J A, Welch K, Bocan T, Tait B, Trivedi B K, Colbry N, Dyer R D, Feinmark S J, Daugherty A

机构信息

Cardiovascular Division, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Br J Pharmacol. 1997 Apr;120(7):1199-206. doi: 10.1038/sj.bjp.0701007.

Abstract
  1. 15-Lipoxygenase (15-LO) has been implicated in the pathogenesis of atherosclerosis because of its localization in lesions and the many biological activities exhibited by its products. To provide further evidence for a role of 15-LO, the effects of PD 146176 on the development of atherosclerosis in cholesterol-fed rabbits were assessed. This novel drug is a specific inhibitor of the enzyme in vitro and lacks significant non specific antioxidant properties. 2. PD 146176 inhibited rabbit reticulocyte 15-LO through a mixed noncompetitive mode with a Ki of 197 nM. The drug had minimal effects on either copper or 2,2'-azobis(2-amidinopropane)hydrochloride (ABAP) induced oxidation of LDL except at concentrations 2 orders higher than the Ki. 3. Control New Zealand rabbits were fed a high-fat diet containing 0.25% wt./wt. cholesterol; treated animals received inhibitor in this diet (175 mg kg-1, b.i.d.). Plasma concentrations of inhibitor were similar to the estimated Ki (197 nM). During the 12 week study, there were no significant differences in weight gain haematocrit, plasma total cholesterol concentrations, or distribution of lipoprotein cholesterol. 4. The drug plasma concentrations achieved in vivo did not inhibit low-density lipoprotein (LDL) oxidation in vitro. Furthermore, LDL isolated from PD 146176-treated animals was as susceptible as that from controls to oxidation ex vivo by either copper or ABAP. 5. PD 146176 was very effective in suppressing atherogenesis, especially in the aortic arch where lesion coverage diminished from 15 +/- 4 to 0% (P < 0.02); esterified cholesterol content was reduced from 2.1 +/- 0.7 to 0 micrograms mg-1 (P < 0.02) in this region. Immunostainable lipid-laden macrophages present in aortic intima of control animals were totally absent in the drug-treated group. 6. Results of these studies are consistent with a role for 15-LO in atherogenesis.
摘要
  1. 15-脂氧合酶(15-LO)因其在病变部位的定位及其产物所表现出的多种生物学活性,而被认为与动脉粥样硬化的发病机制有关。为了进一步证明15-LO的作用,评估了PD 146176对高胆固醇饮食喂养的兔子动脉粥样硬化发展的影响。这种新型药物在体外是该酶的特异性抑制剂,且缺乏显著的非特异性抗氧化特性。2. PD 146176通过混合非竞争性模式抑制兔网织红细胞15-LO,其抑制常数(Ki)为197 nM。该药物对铜或2,2'-偶氮二(2-脒基丙烷)盐酸盐(ABAP)诱导的低密度脂蛋白(LDL)氧化作用极小,除非浓度比Ki高2个数量级。3. 对照新西兰兔喂食含0.25%(重量/重量)胆固醇的高脂饮食;处理组动物在该饮食中加入抑制剂(175 mg·kg-1,每日两次)。抑制剂的血浆浓度与估计的Ki(197 nM)相似。在为期12周的研究中,体重增加、血细胞比容、血浆总胆固醇浓度或脂蛋白胆固醇分布方面均无显著差异。4. 体内达到的药物血浆浓度在体外并未抑制低密度脂蛋白(LDL)氧化。此外,从接受PD 146176处理的动物分离出的LDL与对照动物的LDL在体外对铜或ABAP诱导的氧化敏感性相同。5. PD 146176在抑制动脉粥样硬化形成方面非常有效,尤其是在主动脉弓部位,病变覆盖面积从15±4%降至0%(P<0.02);该区域酯化胆固醇含量从2.1±0.7降至0微克·毫克-1(P<0.02)。对照组动物主动脉内膜中可免疫染色的富含脂质的巨噬细胞在药物处理组中完全不存在。6. 这些研究结果与15-LO在动脉粥样硬化形成中的作用一致。

相似文献

引用本文的文献

3
The role of ferroptosis in intervertebral disc degeneration.铁死亡在椎间盘退变中的作用。
Front Cell Dev Biol. 2023 Jul 27;11:1219840. doi: 10.3389/fcell.2023.1219840. eCollection 2023.
6
Small Molecule Regulators of Ferroptosis.铁死亡小分子调节剂。
Adv Exp Med Biol. 2021;1301:81-121. doi: 10.1007/978-3-030-62026-4_6.
7
12/15 Lipoxygenase as a Therapeutic Target in Brain Disorders.12/15脂氧合酶作为脑部疾病的治疗靶点
Noro Psikiyatr Ars. 2019 Sep 5;56(4):288-291. doi: 10.29399/npa.23646. eCollection 2019 Dec.
10
Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.12/15-脂氧合酶(ALOX15)在人类疾病中的新兴作用。
Prog Lipid Res. 2019 Jan;73:28-45. doi: 10.1016/j.plipres.2018.11.001. Epub 2018 Nov 22.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验